Legendary Entertainment Launches Dune: Future Artifacts, Featuring the Extraordinary Score of Academy Award® Winning Composer, Hans Zimmer
Legendary Entertainment:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210910005448/en/
Dune: Future Artifacts, the digital NFT collection http://dunemovie.com/futureartifacts (Photo: Business Wire)
What: In celebration of the Fall release of Warner Bros. Pictures and Legendary Pictures’ blockbuster film event Dune, Legendary Entertainment, in collaboration with iv gallery, Lineage Studios, and MakersPlace will present an official Dune NFT collection of digital artifacts inspired by the rich world of Denis Villeneuve’s highly anticipated film. This wide-reaching collection, packed with surprises, will include artifacts capturing humanity’s “future history”, from detailed in-world royal portraits of iconic characters taken from the hallowed halls of House Atreides and House Harkonnen to towering sculptures and artifacts unearthed from the shifting sands of Arrakis – known to its inhabitants as Dune.
The Current Dune: Future Artifacts Collection Set to Drop on September 22 features:
- Digital Sculptures – Dune’s most iconic characters, crafted in the likeness of the film’s all-star cast including two editions of Paul Atreides (Timothée Chalamet), Chani (Zendaya), Baron Vladimir Harkkonen (Stellan Skarsgård), Lady Jessica (Rebecca Ferguson), Duncan Idaho (Jason Momoa) and Duke Leto (Oscar Isaac).
- Hans Zimmer’s Dune Score – Every digital sculpture is elevated by the accompaniment of excerpts from the groundbreaking original score of world-renowned composer, Hans Zimmer.
- Spice Artwork – Fans will also have an opportunity to obtain a special limited-edition piece of art celebrating Spice, because as every Dune aficionado knows, he who controls the Spice controls the universe.
The Expanded Collection, Set to Drop in the Coming Weeks (Dates to be Announced):
The excitement of the Dune: Future Artifacts program will continue with additional drops featuring memorabilia and art meant to complete this thrilling digital museum.
Pieces to include…
- A special collection of original pieces from well-known digital artists such as Boss Logic, Matt Griffin and NFN Kalyan
- Additional digital statue sculpts
- Special in-world weaponry, including the storied crysknife
When: The collection launches on September 22nd, with additional artifacts being launched throughout the month of October.
Where: The adventure begins at http://www.dunemovie.com/futureartifacts.
Why: “This collection represents an exciting new direction in the NFT space,” said James Ngo, Executive Vice President of Franchise Management for Legendary Entertainment. “We are thrilled to have created a new collectible experience for the fandom by using exclusive assets taken directly from the film to give enthusiasts a whole new way to not only acquire film memorabilia but also further immerse themselves into the world of Dune.
ABOUT DENIS VILLENEUVE’S DUNE FILM
OSCAR® nominee Denis Villeneuve directed Warner Bros. Pictures and Legendary Pictures’ Dune. The film stars OSCAR® nominee Timothée Chalamet, Rebecca Ferguson, Oscar Isaac, OSCAR® nominee Josh Brolin, Stellan Skarsgård, Dave Bautista, Stephen McKinley Henderson, Zendaya, Chang Chen, David Dastmalchian, Sharon Duncan-Brewster, with OSCAR® nominee Charlotte Rampling, with Jason Momoa, and OSCAR® winner Javier Bardem. Villeneuve directed Dune from a screenplay by Jon Spaihts and Villeneuve and OSCAR® winner Eric Roth, based on the novel of the same name written by Frank Herbert. The film’s producers were OSCAR® nominee Mary Parent, Villeneuve, Cale Boyter and Joe Caracciolo, Jr. The executive producers were Tanya Lapointe, Joshua Grode, Herbert W. Gains, Jon Spaihts, Thomas Tull, Brian Herbert, Byron Merritt and Kim Herbert, with Kevin J. Anderson as special consultant. Warner Bros. Pictures and Legendary Pictures Present a Legendary Pictures Production, a Film by Denis Villeneuve, Dune. The film is slated to be released worldwide this fall, in theaters from 15 September internationally and in the U.S. on October 22 in both theaters and on HBO Max; it will be available on HBO Max in the Ad-Free plan for 31 days from theatrical release. The film has been rated PG-13 for sequences of strong violence, some disturbing images and suggestive material.
ABOUT HANS ZIMMER’S DUNE SCORE
Legendary composer and lifelong Dune fan Hans Zimmer has composed THREE albums of music for Warner Bros. Pictures and Legendary Pictures’ Dune. Now available is the digital album The Dune Sketchbook (Music from the Soundtrack) , which is comprised of extended, immersive musical explorations of the “Dune” film score. September 17th will see the digital album release of Dune (Original Motion Picture Soundtrack) , featuring the iconic composer’s “Dune” film score. And October 22nd is the digital release date for The Art and Soul of Dune - the companion soundtrack to the book of the same title, offering uniquely crafted versions of the film’s main themes curated by Zimmer.
ABOUT LEGENDARY ENTERTAINMENT
Legendary Entertainment is a leading media company with film (Legendary Pictures), television and digital (Legendary Television and Digital Media) and comics (Legendary Comics) divisions dedicated to owning, producing and delivering content to worldwide audiences. Legendary has built a library of marquee media properties and has established itself as a trusted brand which consistently delivers high-quality, commercial entertainment including some of the world's most popular intellectual property. In aggregate, Legendary Pictures-associated productions have realized grosses of more than $18 billion worldwide at the box office. To learn more visit: www.legendary.com.
ABOUT MAKERSPLACE
MakersPlace is the premier NFT marketplace for digital art. Launched in 2018, MakersPlace utilizes blockchain technology to facilitate the sale of authentic, original digital artwork, ensuring rarity and ownership for both creators and collectors. MakersPlace has emphasized accessibility since its inception, and has attracted a large mainstream audience as the first NFT marketplace to accept both cryptocurrency (ETH) and non-cryptocurrency (USD) payments, which it facilitates through crypto wallet and credit card transactions, respectively. MakersPlace helped catapult digital art and NFTs onto the global stage, with the historic sale of Beeple’s Everydays: The First 5000 Days for $69.3 million in partnership with Christie’s auction house in March 2021 – the record price for any digital artwork. Our mission is simple: to enable a vibrant future for digital creativity.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210910005448/en/
Contact information
Brie Dorsey
818-940-2105
bdorsey@legendary.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Receives CHMP Positive Opinion for ALYFTREK ® , a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis28.4.2025 09:03:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ALYFTREK®(deutivacaftor/tezacaftor/vanzacaftor)for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. “Our goal has always been to serially innovate to help people with cystic fibrosis live healthier and longer lives. If approved, this new medicine would be indicated for people with CF ages 6 years and older with at least one non-class I mutation, meaning more patients would be eligible for a medicine that gets them closer to normal levels of sweat chloride,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. “CFTR modulators have already revolutionized the way we treat CF and I am encoura
Prilenia Enters into a Collaboration and License Agreement with Ferrer for the Commercialization and Co-Development of Pridopidine in Europe and Other Select Markets28.4.2025 08:02:00 EEST | Press release
Prilenia Therapeutics B.V., a biopharmaceutical company driven by an unwavering commitment to scientific excellence and accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS), today announced that it has entered into a collaboration and license agreement with Ferrer for the commercialization and further development of pridopidine in Europe and other select markets. Pridopidine is a potent and highly selective, orally administered sigma-1 receptor (S1R) agonist designed to regulate key neuroprotective mechanisms often impaired in neurodegenerative diseases such as HD and ALS. Under the terms of the agreement, Prilenia will receive an upfront payment of approximately €80 million plus up to €45 million in near-term development, regulatory, and commercial milestones. The total deal is valued at up to approximately €500 million in upfront and total milestone payments. In addition, Prilenia will receive tiered double-digit royalties on
Ferrer Enters Into a Collaboration and License Agreement With Prilenia for the Commercialization and Co-Development of Pridopidine28.4.2025 08:00:00 EEST | Press release
Ferrer, an international B Corp pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V.,a clinical-stage biotech company, have announced the signing of a strategic co-development and license agreement in which Ferrer obtains the rights to develop, manufacture and commercialize Pridopidine in the European Region, the Middle East and North African Region, the Southern African Region, the Central and South American Region, and the Commonwealth of Independent States Region. Pridopidine, a potent and highly selective, orally administered sigma-1 receptor agonist, designed to regulate key neuroprotective mechanisms that are often impaired in neurodegenerative diseases, is a promising candidate for the treatment of Huntington’s Disease (HD), a rare inherited neurodegenerative disease, with a high unmet medical need1. It has been studied in more than 1,700 people and long-term safety data of up to 7 years duration are available from previou
Innorna Announces FDA Rare Pediatric Disease and Orphan Drug Designations Granted to IN013 for Treatment of Wilson Disease27.4.2025 12:36:00 EEST | Press release
Innorna, a clinical-stage biotechnology company revolutionizing mRNA therapeutics with its innovative lipid nanoparticle (LNP) delivery technology, today announced the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) to its investigational mRNA therapy, IN013, for treating Wilson Disease (WD). This dual achievement accelerates the clinical development of IN013, advancing Innorna’s mission to deliver transformative therapies for WD patients. About FDA Designations The Rare Pediatric Disease Designation (RPDD) incentivizes therapies for serious or life-threatening diseases affecting fewer than 200,000 U.S. patients, primarily those aged 18 or younger. Sponsors may qualify for a Priority Review Voucher (PRV) upon approval to expedite FDA review of a subsequent drug application. The Orphan Drug Designation (ODD) supports therapies targeting rare diseases (affecting fewer than 200,000 U.S. patients) by provi
Everen Specialty Appoints Carla Greaves Chief Underwriting Officer25.4.2025 20:00:00 EEST | Press release
Everen Specialty, a Bermuda-based (re)insurer for energy markets worldwide, today announced the appointment of Carla Greaves as its new Chief Underwriting Officer (CUO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250425273777/en/ Carla Greaves Ms. Greaves will join the Executive Leadership Team of the Everen Group, based in the Bermuda office, later this year. She succeeds Jane Peterson, Interim CUO, who will continue in a consultancy capacity to facilitate the transition. With more than 30 years of underwriting and leadership experience in the (re)insurance industry, Ms. Greaves brings a wealth of expertise and a proven track record of success in the Casualty market where she is recognized for building high-performing teams, driving profitable growth, and successfully navigating complex market environments. Prior to joining Everen Specialty, Ms. Greaves held increasingly senior leadership positions, most recently servin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom